115 related articles for article (PubMed ID: 23482730)
1. Risk factors for venous thromboembolism in patients with chronic liver disease.
Walsh KA; Lewis DA; Clifford TM; Hundley JC; Gokun Y; Angulo P; Davis GA
Ann Pharmacother; 2013 Mar; 47(3):333-9. PubMed ID: 23482730
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
Barclay SM; Jeffres MN; Nguyen K; Nguyen T
Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
[TBL] [Abstract][Full Text] [Related]
4. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
Reichert JA; Hlavinka PF; Stolzfus JC
Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
[TBL] [Abstract][Full Text] [Related]
6. [Study on the damage of liver in patients with SARS].
Guan YJ; Tang XP; Yin CB; Yi ZQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease.
Smith CB; Hurdle AC; Kemp LO; Sands C; Twilla JD
J Hosp Med; 2013 Oct; 8(10):569-73. PubMed ID: 24101541
[TBL] [Abstract][Full Text] [Related]
8. A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.
Moorehead KJ; Jeffres MN; Mueller SW
J Pharm Pract; 2017 Feb; 30(1):58-63. PubMed ID: 26475125
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
Dabbagh O; Oza A; Prakash S; Sunna R; Saettele TM
Chest; 2010 May; 137(5):1145-9. PubMed ID: 20040609
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
11. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
Duska LR; Garrett L; Henretta M; Ferriss JS; Lee L; Horowitz N
Gynecol Oncol; 2010 Mar; 116(3):374-7. PubMed ID: 19922988
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels.
Grossfeld A; Dekel S; Lerman Y; Sherman S; Atzmony L; Salai M; Justo D
Clin Biochem; 2013 Jan; 46(1-2):54-8. PubMed ID: 23000313
[TBL] [Abstract][Full Text] [Related]
14. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
[TBL] [Abstract][Full Text] [Related]
16. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Sorbi D; Boynton J; Lindor KD
Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
[TBL] [Abstract][Full Text] [Related]
17. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
Haut ER; Lau BD; Kraenzlin FS; Hobson DB; Kraus PS; Carolan HT; Haider AH; Holzmueller CG; Efron DT; Pronovost PJ; Streiff MB
Arch Surg; 2012 Oct; 147(10):901-7. PubMed ID: 23070407
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery.
Nguyen NT; Hinojosa MW; Fayad C; Varela E; Konyalian V; Stamos MJ; Wilson SE
Ann Surg; 2007 Dec; 246(6):1021-7. PubMed ID: 18043105
[TBL] [Abstract][Full Text] [Related]
19. Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.
Kato S; Shimada YJ; Friedmann P; Kashan G; Husk G; Bergmann SR
Coron Artery Dis; 2012 Jun; 23(4):294-7. PubMed ID: 22421548
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
